Aristotle University Of Thessaloniki (AUTH)
Οι διακυμάνσεις της γλυκόζης και του νατριουρητικού πεπτιδίου πλάσματος κατά την οξεία φάση νοσηλείας των ισχαιμικών αγγειακών εγκεφαλικών επεισοδίων διαφορετικής εντόπισης και συσχέτισή τους με την κλινική έκβαση του ασθενή
Abstract
dc:descriptionGlucose fluctuation in Ischemic Stroke (IS) has been studied extensively, yielding significant results. Patients with IS, frequently have a high serum glucose level, regardless of pre-existing diabetes mellitus, which is caused by stress hyperglycemia (serum glucose level > 140 mg/dl in hospitalized patients without prior diabetes). Literature suggests, hyperglycemia can be detrimental to the ischemic brain. Also, when brain tissue is damaged, levels of the natriuretic peptide (NT-proBNP) increases. Aim: The aim of this study is to investigate the possible correlation of plasma glucose fluctuation and natriuretic peptide (NT-proBNP), with the infarct topography and the patient outcome after IS for a period of up to 6 months after discharge. This is a non-interventional prospective observational study that did not modify the routine clinical management of the patients. The study protocol was approved by the Ethics Committee of the School of Medicine of the Aristotle University of Thessaloniki. Sample: The present study included patients aged 65 years and older, who were admitted to the 1st Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA University Hospital, during the period 2020-2022. Exclusion criteria were: Transient ischemic episode, modified Rankin Scale score >2 due to previous stroke, febrile condition, presence of neoplasia and thrombolysis. Method: Patients underwent clinical, imaging and biochemical tests. Those who met the inclusion criteria were informed and consented, either themselves, or by a first degree relative. A glucose sensor was placed for 72 hours and patients’ functional status was assessed with the modified Rankin Scale at admission, at discharge, at 1st, 3rd and 6th month. Results: The study sample consisted of 105 patients, with an average age of 80.95 years. Based on topography (Oxford classification) patients with total anterior, partial anterior, posterior circulation and lacunar infarcts were, respectively, 25, 32, 23 and 25. On admission, mean plasma glucose was 146.14 mg/dl. The mean value of NT-proBNP was 3433.92 pg/mL. The overall mean glucose, glycemic variability, and percent time glucose within glycemic range 70–140 mg/dL were calculated to be 127.06 mg/dL, 13.06%, and 70.98%, respectively. There was no statistically significant difference between age and genders regarding the topography of IS. Regarding the relationship between topography and total average glucose or NT-proBNP, the statistical tests did not show a significant difference in the averages of the variables. It was observed that: For each year of increase in age (65 years and older), a 7.4% increase in the odds of a worse outcome and a 16% increase in the risk of death is expected. For each unit increase in percent glucose time within the range of 70–140 mg/dL, a 1.5% reduction in the odds of a worse outcome is expected. Patients with total anterior infarcts were 2.31 times more likely to have a worse outcome than patients with lacunar infarcts. Conclussions: The categorization of IS according to Oxford classification cannot be used in the context of the management of hyperglycemia during the acute phase of hospitalization of patients (72 h after infarction). However, improvement in glucose levels, time in the glycemic range 70–140 mg/dl and Nt-proBNP levels are associated with a reduced risk of death and a better prognosis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Fountouki, Antigoni
- Φουντούκη, Αντιγόνη
Subjects
dc:subject × 14- Εγκεφαλικό επεισόδιο
- Υπεργλυκαιμία
- Συνεχής καταγραφή γλυκόζης
- Νατριουρητικό πεπτίδιο NT-proBNP
- Acute stroke
- Hyperglycemia
- Continuous glucose monitoring (CGM) system
- Natriouretic peptide
- Βασική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Βασική ιατρική, γενικά
- Basic Medicine
- Medical and Health Sciences
- Basic medicine, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/57028